In April, the 75th China International Medical Equipment (Spring) Expo (CMEF) ended in Shanghai, with more than 4,000 domestic and foreign manufacturers gathered, and a number of new medical device products were released, which attracted attention. The hottest topic at the exhibition is nothing more than the challenges and opportunities of domestic and foreign medical device companies. For domestic medical device companies, high-end manufacturing still has technical difficulties, but the policy benefits bring more opportunities for innovative R&D and market occupation. For foreign medical device companies, the monopoly advantage and market dividend brought by technology leadership are gradually increasing. Shrinking water and finding new opportunities are the future directions. For a long time, foreign medical device manufacturers have controlled high-end medical equipment in the Chinese market by as much as 70%. According to the Prospective Industry Research Institute's "2014-2018 China Medical Device Industry Market Outlook and Investment Forecast Analysis Report", in China's medical device field, about 80% of the CT market, 90% of the ultrasonic instrument market, and 85% of the inspection instruments. The market, 90% of magnetic resonance equipment, 90% of the ECG market, 80% of the high-end monitor market, and 90% of the high-end physiological recorder market are monopolized by foreign companies. In some areas, the coverage of imported equipment can reach 100%. To encourage the development of domestic medical devices. Since 2014, China’s top management has repeatedly proposed the development of domestic medical devices. The “Regulations on the Supervision and Administration of Medical Devices†and the “Special Approval Process for Innovative Medical Devices†have clearly stated that priority is given to purchasing domestic medical devices in the tendering process. The development of medical device companies in China is highly constrained. On March 11 this year, the "Guiding Opinions of the General Office of the State Council on Promoting the Healthy Development of the Pharmaceutical Industry" clearly pointed out that "it will accelerate the transformation and upgrading of medical devices as a key point, focusing on the development of a variety of high-performance medical equipment and high-end products in rehabilitation aids. "This is regarded by the industry as a sign that domestic medical devices are entering high-end manufacturing. Kevin Hobert, President of Carestream Global, the world's largest medical equipment and IT supplier, accepted an exclusive interview with Caixin. He believes that China's "Internet + medical" is accelerating, and there are unlimited opportunities and possibilities for high-end medical devices and medical informationization . In terms of China's primary health care and hospital informationization, low-cost programs are needed, which requires foreign companies to have more “localization†capabilities. In addition, China's policy environment for foreign-funded medical enterprises is gradually tightening, and basic medical and private hospitals are new opportunities for foreign-invested medical enterprises. Established in 2007, Carestream Health is a subsidiary of Onex Corporation of Toronto, Canada, which acquired the Eastman Kodak Medical Group. As a professional innovation department of the Kodak Group, Carestream Health and many US universities, the US Navy, and American Football Alliances and so on have partnerships. Pipe Fittings,Pipe Bracket,Clamp Ferrule,Ss304 Clamp Wenzhou Gaoya Light Industry Machinery Co.,ltd. , https://www.hongyafitting.com